Full Text Available
Note: Clicking the button above will open the full text document at the original institutional repository in a new window.
Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): protocol and statistical analysis plan for a randomized controlled trial
Background: Postpartum haemorrhage (PPH) is a leading cause of maternal death. Tranexamic acid has the potential to reduce bleeding and a large randomized controlled trial of its effect on maternal health outcomes in women with PPH (The WOMAN trial) is ongoing. We will examine the effect oftranexami...
Saved in:
| Format: | Article |
|---|---|
| Published: |
2016
|
| Tags: |
No Tags, Be the first to tag this record!
|
Similar Items: Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): protocol and statistical analysis plan for a randomized controlled trial
- Effect of tranexamic acid on coagulation and fibrinolysis in women with postpartum haemorrhage (WOMAN-ETAC): a single-centre, randomised, double-blind, placebo-controlled trial
- Postpartum Haemorrhage
- Tranexamic acid for acute gastrointestinal bleeding (the HALT-IT trial): statistical analysis plan for an international, randomised, double-blind, placebo-controlled trial
- WHO Recommendations for the Prevention of Postpartum Haemorrhage
- Burden and outcomes of postpartum haemorrhage in Nigerian referral-level hospitals.
- Intravenous tranexamic acid for reducing blood loss during caesarean delivery: a randomized, double-blind, placebo-controlled trial